Canada Newswire, November 6, 2011
Dr. Mark Gelfer, a family physician with the Copeman Healthcare Centre in Vancouver was awarded the prestigious Certificate of Excellence from Hypertension Canada “in recognition of his outstanding efforts and contributions in Canada to increase public awareness, prevention and control of hypertension”. The award was presented at the Canadian Hypertension Congress held in Ontario this past October.
Hypertension, also commonly referred to as high blood pressure, affects nearly 6 Million Canadians, 24% of women and 21% of men. According to the Heart and Stroke Foundation the incidence of hypertension is set to nearly double in the next 15 years, making it a national crisis. Left untreated, hypertension can lead to heart attack, stroke, chronic kidney failure, dementia and even blindness.
“It was a great honour to be recognized by Hypertension Canada with this award. We are making great progress in identifying and managing Canadians at risk for catastrophic health consequences because of high blood pressure and I feel privileged to be involved in the Hypertension Program at the Copeman Healthcare Clinic”.
Dr. Gelfer’s expertise in the diagnosis and management of hypertension has been instrumental in setting up the Hypertension Programs at the private Copeman Healthcare Clinics in Vancouver and Calgary. The integrated services of the Copeman clinics combine health assessments with education and the specialized services of registered dietitians, kinesiologists and health coaches to help reduce risk of cardiovascular events.
Dr. Gelfer completed his medical degree at the University of Toronto and his residency in Family Medicine at the University of Ottawa.
He has served as President of the College of Family Physicians of British Columbia and is currently a Clinical Assistant Professor at the University of British Columbia. Prior to joining Copeman Healthcare he was the founder and Medical Director of VSM MedTech Ltd., and developed the BpTru, a tool that has become a standard instrument for monitoring hypertension in the clinical setting.